Vancouver, BC, Canada

604-727-3014

  • LinkedIn Social Icon

©2017 BY SANOTIZE RESEARCH AND DEVELOPMENT CORP.

NORS2791 for Acne  

 

NORS2791 product candidate will be a topical formulation of NORS for the treatment of acne infections, a chronic, inflammatory skin condition. The NORS will be delivered as a topical gel.

Acne is the most common skin care problem seen by doctors. It occurs when pores become clogged by a combination of an oily substance produced by the skin called sebum, dirt, and dead skin cells.

Often, bacteria called Propionibacterium acnes, is present, which can contribute to the redness, swelling and pus that can accompany lesions. 

More than 90 percent of world population is affected by acne at some point in their life. Around 20% of the US population is affected with acne every year with an approximate $5 billion market.

NORS may inhibit production of the pore-clogging cytokines in acne as well as act as an antibacterial. It was shown to be highly effective at killing P. acnes. In addition to its bactericidal properties, SaNOtize's acne treatment is expected to reduce inflammation and thus, symptoms.